RCAMU
ABBV icon

Rothschild & Co Asset Management US’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$92.6M Buy
573,199
+9,640
+2% +$1.56M 1.41% 25
2022
Q3
$75.6M Sell
563,559
-42,251
-7% -$5.67M 1.29% 26
2022
Q2
$92.8M Sell
605,810
-175,628
-22% -$26.9M 1.42% 20
2022
Q1
$127M Buy
781,438
+15,561
+2% +$2.52M 1.62% 14
2021
Q4
$104M Sell
765,877
-14,397
-2% -$1.95M 1.22% 24
2021
Q3
$84.2M Sell
780,274
-8,865
-1% -$956K 1.04% 34
2021
Q2
$88.9M Buy
789,139
+29,800
+4% +$3.36M 1.05% 33
2021
Q1
$82.2M Buy
759,339
+19,996
+3% +$2.16M 1.01% 31
2020
Q4
$79.2M Buy
739,343
+332,039
+82% +$35.6M 1.02% 25
2020
Q3
$35.7M Sell
407,304
-169,507
-29% -$14.8M 0.64% 40
2020
Q2
$56.6M Buy
+576,811
New +$56.6M 0.83% 16
2019
Q1
Sell
-216,893
Closed -$20M 364
2018
Q4
$20M Sell
216,893
-257,492
-54% -$23.7M 0.24% 162
2018
Q3
$44.9M Sell
474,385
-138,894
-23% -$13.1M 0.46% 67
2018
Q2
$56.8M Buy
613,279
+26,016
+4% +$2.41M 0.61% 28
2018
Q1
$55.6M Sell
587,263
-123,350
-17% -$11.7M 0.62% 31
2017
Q4
$68.7M Buy
710,613
+700,931
+7,240% +$67.8M 0.73% 24
2017
Q3
$860K Sell
9,682
-10,462
-52% -$929K 0.01% 325
2017
Q2
$1.46M Sell
20,144
-1,691
-8% -$123K 0.02% 347
2017
Q1
$1.42M Sell
21,835
-1,516
-6% -$98.8K 0.02% 349
2016
Q4
$1.46M Buy
23,351
+3,561
+18% +$223K 0.02% 362
2016
Q3
$1.25M Buy
19,790
+1,734
+10% +$109K 0.02% 339
2016
Q2
$1.12M Buy
18,056
+6,021
+50% +$373K 0.02% 353
2016
Q1
$687K Buy
12,035
+3,432
+40% +$196K 0.01% 321
2015
Q4
$510K Buy
8,603
+1,349
+19% +$80K 0.01% 342
2015
Q3
$395K Sell
7,254
-330,063
-98% -$18M 0.01% 336
2015
Q2
$22.7M Buy
337,317
+197,447
+141% +$13.3M 0.42% 68
2015
Q1
$8.19M Buy
139,870
+129,473
+1,245% +$7.58M 0.16% 214
2014
Q4
$680K Hold
10,397
0.01% 340
2014
Q3
$601K Sell
10,397
-880
-8% -$50.9K 0.01% 338
2014
Q2
$636K Sell
11,277
-180
-2% -$10.2K 0.01% 345
2014
Q1
$589K Buy
11,457
+2,231
+24% +$115K 0.01% 354
2013
Q4
$487K Sell
9,226
-86
-0.9% -$4.54K 0.01% 359
2013
Q3
$417K Sell
9,312
-170
-2% -$7.61K 0.01% 360
2013
Q2
$392K Buy
+9,482
New +$392K 0.01% 360